We've heard plenty of testimony today about the timeline here that in 2007, Purdue Pharma pleaded guilty to illegally misbranding OxyContin in this effort to mislead doctors and patients about the drug's risk of addiction.
Editor's note · Context
John Sarbanes discusses Purdue Pharma's past legal issues regarding OxyContin's marketing.
Share
More from John Sarbanes
These are successes that are going to create new jobs. They are going to strengthen our domestic clean energy production.
I thank the chairman for yielding and recognizing me. Madam Chair, I rise in strong opposition to the Republicans' energy bill. I have deep concerns about this package overall in terms of its attack on our bedrock environmental laws. As a…
I hope that today's hearing is the first step in continuing that legacy of strong bipartisan support for the Chesapeake Bay in this Congress.
As the Inflation Reduction Act reforms continue to be implemented over the coming years, we must continue to build on this success.





